Kandel-Kfir et al. suggested a mechanism by which IFN-γ treated hepatocellular carcinoma (HCC) cells showed increased expression and acetylation of myocyte enhancer factor 2D which further promoted PD-L1 synthesis [136]. This evidence concerns the gene MEF2D and hepatocellular carcinoma.